In a randomized trial using PET-MRI to assess carotid plaque inflammation, semaglutide did not show a significant difference versus placebo on the prespecified primary plaque-inflammation endpointslikely influenced by low baseline inflammatory burden in a well-treated population. How to interpret this: Imaging studies like this are helpful for understanding mechanisms and terminology (e.g., atherosclerotic inflammation, PET-MRI plaque imaging), but they do not establish semaglutide as a direct vascular inflammation imaging reducer in general clinical use based on current evidence. 5) They Improve Kidney Outcomes in High-Risk Populations (Semaglutide) By improving glycemic control and metabolic stress, GLP-1 therapies can reduce kidney risk in susceptible patients
Retrieved January 28, 2017
If you are concerned discuss this with your doctor or a The Family Chemist clinician
Noticing changes
Vitamin C may be a good option if you: Want additional collagen support Prefer obtaining nutrients through diet Are looking for antioxidant protection Use topical skincare products regularly Who Should Choose Glutathione
Real-world evidence, including patient surveys and medical records, often shows a higher incidence of side effects than clinical trials due to the diverse health conditions and lifestyles of participants
